Articles with public access mandates - Lorenzo MorettaLearn more
OverallGovernment of ItalyAIRC Foundation for Cancer Research in ItalyEuropean CommissionNIHWellcomeNHMRCDFGMRCSwedish Research CouncilARCCancer Research UKFondazione CariploANRSNSFFWORCNGovernment of SpainSCLGenome CanadaNSERCNSFCLeibniz AssociationNWOBBSRCNIHRWorldwide Cancer Research, UKBMBFLeducq Foundation, USASusan G. Komen
Not available anywhere: 13
Human natural killer cells: origin, receptors, function, and clinical applications
L Moretta, E Montaldo, P Vacca, G Del Zotto, F Moretta, P Merli, F Locatelli, ...
International archives of allergy and immunology 164 (4), 253-264, 2014
Mandates: Government of Italy
NK cells mediate a crucial graft-versus-leukemia effect in haploidentical-HSCT to cure high-risk acute leukemia
F Locatelli, D Pende, M Falco, M Della Chiesa, A Moretta, L Moretta
Trends in immunology 39 (7), 577-590, 2018
Mandates: Government of Italy
Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia
C Quintarelli, S Sivori, S Caruso, S Carlomagno, M Falco, I Boffa, ...
Leukemia 34 (4), 1102-1115, 2020
Mandates: Government of Italy, AIRC Foundation for Cancer Research in Italy
Human innate lymphoid cells
E Montaldo, P Vacca, C Vitale, F Moretta, F Locatelli, MC Mingari, ...
Immunology letters 179, 2-8, 2016
Mandates: Government of Italy
Development of human natural killer cells and other innate lymphoid cells
E Montaldo, P Vacca, L Moretta, MC Mingari
Seminars in immunology 26 (2), 107-113, 2014
Mandates: Government of Italy
Dendritic cell editing by natural killer cells
G Ferlazzo, L Moretta
Critical Reviews™ in Oncogenesis 19 (1-2), 2014
Mandates: Government of Italy
KIR and KIR ligand polymorphism: a new area for clinical applications?
M Falco, L Moretta, A Moretta, C Bottino
Tissue Antigens 82 (6), 363-373, 2013
Mandates: Government of Italy
NK-cell editing mediates epithelial-to-mesenchymal transition via phenotypic and proteomic changes in melanoma cell lines
L Huergo-Zapico, M Parodi, C Cantoni, C Lavarello, ...
Cancer research 78 (14), 3913-3925, 2018
Mandates: Government of Spain
Boosting natural killer cell-based immunotherapy with anticancer drugs: a perspective
L Cifaldi, F Locatelli, E Marasco, L Moretta, V Pistoia
Trends in Molecular Medicine 23 (12), 1156-1175, 2017
Mandates: Government of Italy
Human NK cells: From surface receptors to clinical applications
L Moretta, G Pietra, P Vacca, D Pende, F Moretta, A Bertaina, MC Mingari, ...
Immunology letters 178, 15-19, 2016
Mandates: Government of Italy
HO‐1 downregulation favors BRAFV600 melanoma cell death induced by Vemurafenib/PLX4032 and increases NK recognition
AL Furfaro, S Ottonello, G Loi, I Cossu, S Piras, F Spagnolo, P Queirolo, ...
International Journal of Cancer 146 (7), 1950-1962, 2020
Mandates: Government of Italy, AIRC Foundation for Cancer Research in Italy
Natural killer cell receptors regulate responses of HLA-E–restricted T cells
LC Sullivan, THO Nguyen, CM Harpur, S Stankovic, AR Kanagarajah, ...
Science immunology 6 (58), eabe9057, 2021
Mandates: National Health and Medical Research Council, Australia
Determining Endosomal Toll-Like Receptors Gene Expression in NK Cells After Stimulation with Specific Agonists
C Alicata, I Veneziani, B Ricci, L Moretta, E Maggi
Toll-Like Receptors: Methods and Protocols, 151-162, 2023
Mandates: AIRC Foundation for Cancer Research in Italy
Available somewhere: 152
Guidelines for the use of flow cytometry and cell sorting in immunological studies
A Cossarizza, HD Chang, A Radbruch, A Acs, D Adam, S Adam‐Klages, ...
European journal of immunology 49 (10), 1457-1973, 2019
Mandates: Swiss National Science Foundation, US National Institutes of Health, Genome …
Classification of current anticancer immunotherapies
L Galluzzi, E Vacchelli, JM Bravo-San Pedro, A Buqué, L Senovilla, ...
Oncotarget 5 (24), 12472, 2014
Mandates: US National Institutes of Health, National Health and Medical Research …
Human NK cells: surface receptors, inhibitory checkpoints, and translational applications
S Sivori, P Vacca, G Del Zotto, E Munari, MC Mingari, L Moretta
Cellular & molecular immunology 16 (5), 430-441, 2019
Mandates: Government of Italy
Effect of tumor cells and tumor microenvironment on NK‐cell function
M Vitale, C Cantoni, G Pietra, MC Mingari, L Moretta
European journal of immunology 44 (6), 1582-1592, 2014
Mandates: Government of Italy
Killer Ig-like receptors (KIRs): their role in NK cell modulation and developments leading to their clinical exploitation
D Pende, M Falco, M Vitale, C Cantoni, C Vitale, E Munari, A Bertaina, ...
Frontiers in immunology 10, 1179, 2019
Mandates: Government of Italy
A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes
YT Bryceson, D Pende, A Maul-Pavicic, KC Gilmour, H Ufheil, T Vraetz, ...
Blood, The Journal of the American Society of Hematology 119 (12), 2754-2763, 2012
Mandates: Swedish Research Council
Outcome of children with acute leukemia given HLA-haploidentical HSCT after αβ T-cell and B-cell depletion
F Locatelli, P Merli, D Pagliara, G Li Pira, M Falco, D Pende, R Rondelli, ...
Blood, The Journal of the American Society of Hematology 130 (5), 677-685, 2017
Mandates: Government of Italy
Publication and funding information is determined automatically by a computer program